Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 n-Lorem Foundation Partners with Argonaut Manufacturing Services | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

n-Lorem Foundation Partners with Argonaut Manufacturing Services

Will make ASO medicines for patients with nano-rare diseases.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Argonaut Manufacturing Services, a contract manufacturing organization (CMO), and n-Lorem, a nonprofit foundation, have formed a new partnership that supports and reduces the cost of manufacturing of n-Lorem’s experimental antisense oligonucleotide (ASO) medicines developed for nano-rare disease patients (1 to 30 patients worldwide) for free, for life. 

“Providing nano-rare patients, who would otherwise be largely ignored by our current drug discovery paradigm, with a personalized approach for free is a remarkable undertaking and one that requires the commitment of many people and organizations,” said Stanley T. Crooke, founder, CEO and chairman of n-Lorem Foundation. “We are pleased to add Argonaut to our growing list of the industry’s best to support the highest-quality drug discovery, development, and manufacturing for our patients. Reducing the cost of manufacturing translates into lower per-patient costs, which is important for our non-profit and important for our patients who depend upon us and our partners. At n-Lorem, we are fortunate that our partners can integrate seamlessly and efficiently with us and together we work toward making a difference for our nano-rare patient today and tomorrow.”

Wayne Woodard, founder and CEO, Argonaut, said, “At Argonaut, we are incredibly proud to be working with this distinguished group of experts at the n-Lorem Foundation. We are focused on delivering the best contract manufacturing support to the innovators and creators, in the biopharma industry. Partnering with the n-Lorem Foundation provides us with the unique opportunity to apply our leading aseptic drug product manufacturing technology in support of nano-rare patients. I have been impressed with Stan’s vision and leadership with n-Lorem’s charitable approach, and the overall progress of the foundation in such a short time. We are committed strategic partners as we understand that there are > 7,000 known rare to nano-rare diseases. Stan and I share a vision that these patient groups will have access to the life improving or lifesaving drugs that need to be developed. As such, we are honored to work with n-Lorem.”

Learn more about n-Lorem’s mission at www.nlorem.org, and please consider giving to n-Lorem to bring hope, possibility and treatment options to these needy patients and families.

Watch: n-Lorem Foundation Delivers Hope and Treatment for Patient with Nano-Rare Disease
Watch: n-Lorem Foundation: Creating a Better Future for Nano-Rare, One Patient at a Time

Learn more about Argonaut Manufacturing Services, Inc. parenteral injectable aseptic fill finish services. Argonaut will also be establishing a donation campaign on its website and be available at select conferences with n-Lorem leaders and patients throughout the year to advance the education and ability for n-Lorem and the community to save patients lives, an “n of 1” at a time.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics